Homeβ€ΊSearchβ€ΊEndokrynologia Polska

Endokrynologia Polska

Via Medica Β· Poland Β· Est. 1950

ISSN2299-8306
SJR Q3βœ“ WOS SCIEβœ“ Scopus / SJRβœ“ DOAJβœ“ Open Access
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
20
weeks to publish Β· journal-reported
Average Β· vs ~15 wk median
Q3
SJR Rank
Top 75% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q3 Β· Scopus CiteScore 3.6. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.501
H-Indexi
38
CiteScorei
3.6
SNIPi
0.614
Total Worksi
1,141
Total Citationsi
9,653
2yr Mean Citednessi
1.16
Open Impact Factor alternative

Aims & Scope

The journal is dedicated to the dissemination of high-quality research in clinical and experimental endocrinology, diabetology, and metabolic diseases. It is addressed to endocrinologists, diabetologists, internists, clinical researchers, and other specialists involved in the diagnosis, treatment, and study of endocrine and metabolic disorders, as well as to professionals working in related areas of biomedical and health sciences.

General Information

Country / RegionPoland
Primary LanguageEnglish, Polish
1st Year Published1950
Frequencybimonthly
StatusActive
Total Publications1,141
Publisher OrgVia Medica
Visit Journal Website

Submission Info

Peer ReviewDouble-blind
Review Time~20 weeks
Acceptance Rate25%
OA LicenseCC BY-NC-ND
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes
πŸ“¦ Long-term Preservation
Portico

Think.Check.Submit Compliance

10/12 Β· 83%
βœ…
Do you know the journal / publisher?
Via Medica
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
2299-8306
βœ…
Indexed in a trusted database?
WoS, Scopus, DOAJ
βœ…
Peer review process documented?
Double-blind
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
βœ…
Long-term digital preservation?
Portico
βœ…
Plagiarism detection in place?
Yes
βœ…
Listed in DOAJ (verified OA)?
DOAJ verified
βœ…
Primary language documented?
English, Polish

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
69
743
2019
108
1k
2020
103
762
2021
100
660
2022
89
379
2023
94
212
2024
93
88
2025
44
1
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Endocrinology, Diabetes and MetabolismQ3
EndocrinologyQ4

Subject Classification

Web of Science Categories

Endocrinology & Metabolism

Scopus Categories

Endocrinology, Diabetes and MetabolismEndocrinology

Research Topics (OpenAlex)

Thyroid Cancer Diagnosis and TreatmentThyroid Disorders and TreatmentsPituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research AdvancesThyroid and Parathyroid SurgeryParathyroid Disorders and TreatmentsAdrenal and Paraganglionic TumorsGrowth Hormone and Insulin-like Growth FactorsAdipokines, Inflammation, and Metabolic DiseasesAdrenal Hormones and Disorders

Frequently asked questions about Endokrynologia Polska

Is Endokrynologia Polska a predatory journal?

PubScope has no integrity flags on record for Endokrynologia Polska: it is indexed in Web of Science, Scopus, DOAJ, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Endokrynologia Polska?

Endokrynologia Polska is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. As an open alternative, its Scopus CiteScore is 3.6.

Is Endokrynologia Polska indexed in Scopus and Web of Science?

Endokrynologia Polska is indexed in Web of Science, Scopus, DOAJ.

What is the aims and scope of Endokrynologia Polska?

The journal is dedicated to the dissemination of high-quality research in clinical and experimental endocrinology, diabetology, and metabolic diseases. It is addressed to endocrinologists, diabetologists, internists, clinical researchers, and other specialists involved in the diagnosis, treatment, and study of endocrine and metabolic disorders, as well as to professionals working in related areas of biomedical and health sciences.

What is the acceptance rate of Endokrynologia Polska?

Endokrynologia Polska lists a self-reported acceptance rate of approximately 25%. Journal-reported figures can be optimistic β€” treat it as a rough guide, not a guarantee.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref